Literature DB >> 3826110

Rapid response to acyclovir in herpes zoster-associated encephalitis.

D R Johns, D R Gress.   

Abstract

A previously healthy patient became acutely encephalopathic, with complete disorientation and amnesia, several days after the onset of thoracic herpes zoster. She had transiently abnormal electroencephalographic results, abnormalities on radionuclide brain scanning, and cerebrospinal fluid pleocytosis. There was no evidence of a toxic/metabolic encephalopathy except for a mildly elevated ammonia level. Intravenously administered acyclovir (30 mg/kg per day) induced a dramatic response, with complete resolution of the encephalopathy within 72 hours and normalization of the electroencephalographic results. The scant clinical experience with the successful use of acyclovir in the treatment of herpes zoster-associated encephalitis is reviewed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826110     DOI: 10.1016/0002-9343(87)90463-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Herpes zoster meningoencephalitis without rash: varicella zoster virus DNA in CSF.

Authors:  K F Powell; H G Wilson; M O Croxson; M R Marshall; E H Wong; N E Anderson; M G Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

Review 2.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 3.  Recognition and treatment of shingles.

Authors:  A F Nikkels; G E Piérard
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

4.  Shingles (Herpes Zoster) and Post-herpetic Neuralgia.

Authors:  Larry E. Davis; Molly K. King
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.972

5.  Subcortical type cognitive impairment in herpes zoster encephalitis.

Authors:  L Hokkanen; J Launes; E Poutiainen; L Valanne; O Salonen; J Sirén; M Iivanainen
Journal:  J Neurol       Date:  1997-04       Impact factor: 6.682

Review 6.  Antiviral agents.

Authors:  E D Reines; P A Gross
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.